These 5 “Magic Formula” Biotech Stocks Are Guru Approved
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
Yields
This Laggard Medical-Device Stock Could Get A Shot In The Arm
While the medical-device stock highlighted in today’s article is up nearly 20% this year, it lags the S&P 500 and the core medical-device exchange-traded fund.…
No Signs Of The “Retail Apocalypse” With These Dividend Payers
Behind the high-profile bankruptcy stories and talk of a “retail apocalypse” as more and more buying takes place online, the author of today’s article notes…
“The Most Blatant Warning” For The Stock Market That’s Being Overlooked
From the yield curve inversion (which has preceded every recession since the end of World War II) to the very high – and rising –…
“The Best Way To Invest In Retail”
While the rise of e-commerce giants such as Amazon has certainly brought about the demise of many brick-and-mortar retailers (with many more victims undoubtedly to…
The Dividend Yield Sweet Spot – And 6 Funds That Hit It
How can you go about getting safer, higher income? Consider high dividend stocks that hit the yield sweet spot, which one fund researcher cited in…
How This ETF Looks Beyond Yield To Find Quality, Undervalued, Safe Dividend Stocks
The author of today’s article seeks out quality dividend paying ETFs – and in today’s article he highlights one such fund: “an ETF that invests…
3 Dividend Stocks With The Good Kind Of Deep Value
When is a dividend stock that the market is especially bearish on a deep value buying opportunity and when is it a yield/value trap? The…
The Trends Appear To Be The Friends Of These 3 REITs
A flat yield curve, stronger corporate profits, and continued growth in e-commerce sales are three trends that the author of today’s article believes will drive…
Use This Gauge To Identify Value Stocks That Could Outperform (Such As These 12 Top Picks)
If you’re looking for inexpensive opportunities for big gains in this stock market that is extremely pricey by most metrics, Goldman Sachs has formulated one…